Regulation And Legal
Wockhardt Zaynich® Gets CDSCO SEC Favourable Recommendation
CDSCO's Subject Expert Committee granted a favourable recommendation for marketing permission of Wockhardt's novel antibiotic Zaynich® (Zidebactam/Cefepime) for Gram-negative infections.
Zaynich® demo
